JPS6447393A - Novel physiologically active polypeptide - Google Patents

Novel physiologically active polypeptide

Info

Publication number
JPS6447393A
JPS6447393A JP62203431A JP20343187A JPS6447393A JP S6447393 A JPS6447393 A JP S6447393A JP 62203431 A JP62203431 A JP 62203431A JP 20343187 A JP20343187 A JP 20343187A JP S6447393 A JPS6447393 A JP S6447393A
Authority
JP
Japan
Prior art keywords
polypeptide
physiologically active
active polypeptide
antitumor
acid sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP62203431A
Other languages
Japanese (ja)
Inventor
Satoshi Nakamura
Tsukio Sakugi
Kazuo Kitai
Yataro Ichikawa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Teijin Ltd
Original Assignee
Teijin Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teijin Ltd filed Critical Teijin Ltd
Priority to JP62203431A priority Critical patent/JPS6447393A/en
Publication of JPS6447393A publication Critical patent/JPS6447393A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • C07K14/525Tumour necrosis factor [TNF]

Abstract

PURPOSE:To produce a physiologically active antitumor polypeptide, by forming a DNA region coding a physiologically active polypeptide expressed by a specific amino acid sequence or a polypeptide having Met bonded to the amino terminal of the above polypeptide. CONSTITUTION:A recombinant microbial cell containing a DNA region coding a physiologically active polypeptide expressed by an amino acid sequence of formula I or a polypeptide having Met bonded to the amino terminal of the above polypeptide is cultured to produce and accumulate a physiologically active polypeptide in the cultured product. The objective physiologically active polypeptide is separated from the cultured product. The polypeptide is an antitumor polypeptide different from conventional human TNF protein and provides a pharmaceutical composition having excellent antitumor activity.
JP62203431A 1987-08-18 1987-08-18 Novel physiologically active polypeptide Pending JPS6447393A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP62203431A JPS6447393A (en) 1987-08-18 1987-08-18 Novel physiologically active polypeptide

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP62203431A JPS6447393A (en) 1987-08-18 1987-08-18 Novel physiologically active polypeptide

Publications (1)

Publication Number Publication Date
JPS6447393A true JPS6447393A (en) 1989-02-21

Family

ID=16473973

Family Applications (1)

Application Number Title Priority Date Filing Date
JP62203431A Pending JPS6447393A (en) 1987-08-18 1987-08-18 Novel physiologically active polypeptide

Country Status (1)

Country Link
JP (1) JPS6447393A (en)

Similar Documents

Publication Publication Date Title
HK66289A (en) Human immune interferon and its production by recombinant dna technology
AU2790292A (en) Viral recombinant vectors for expression in muscle cells
ES8607391A1 (en) Yeast hybrid vectors and their use for the production of polypeptides.
CA2062969A1 (en) Recombinantly produced human membrane cofactor protein (mcp)
EP0218531A3 (en) Immunogenic peptides of human interleukin-1 and the corresponding anti-peptide antibodies
CA2032167A1 (en) Dna coding for protein binds to enhancer of.alpha.-fetoprotein gene
JPS6447393A (en) Novel physiologically active polypeptide
CA2011378A1 (en) Achromobacter protease i gene and gene product thereof
ES8605296A1 (en) Recominant factor VIII-R.
JPS6427495A (en) Novel physiologically active polypeptide
CA2089111A1 (en) Smooth muscle mitogen and isolated dna coding therefor
EP0238275A3 (en) Recombinant product
EP0249854A3 (en) Novel polypeptide
JPS6437299A (en) Novel physiologically active polypeptide
JPS6423899A (en) Novel physiologically active polypeptide
IT1186793B (en) FRACTION OBTAINED FROM LISTERIA MONOCYTOGENES WITH THERAPEUTIC ACTIVITY, PROCEDURE FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN IT